Blackford Middleton signs on with Apervita

Blackford Middleton, MD, MPH, MS, has joined Apervita as chief informatics and innovation officer.

Middleton was most recently chief informatics officer at Vanderbilt University and is immediate past chair of the board of directors of the American Medical Informatics Association (AMIA).

"Blackford Middleton has pioneered the application of the world's health knowledge to the challenge of providing the best care," said Paul Magelli, Apervita CEO. "His expertise and passion are an ideal match with Apervita's mission to empower health enterprises and professionals to make their health knowledge computable and exchangeable, enabling its use on an industry scale. We are thrilled to have Dr. Middleton join our team as we enable health's front-runners to realize the profound benefits of this promise."

At Apervita, Middleton will be responsible for working with the ecosystem of leading health enterprises, including major health systems, payers and pharmaceutical companies, to shape an industry platform to enable these enterprises to readily apply health knowledge throughout their business.

"The health enterprises using Apervita are poised to make a direct impact on global health by applying the wealth of today's health knowledge," Middleton said in a release. "There are estimated to be hundreds of thousands of health algorithms in the world today, for example, that address major and pervasive health problems such as chronic disease, yet relatively few are connected to health data beyond research. Apervita has developed an innovative platform that enables enterprises to readily connect health knowledge with health data and deploy it broadly across its business as well as share it with others. Every health enterprise should be assessing the potential and benefit of this approach. I have joined Apervita as its mission, platform and team align with my long-held belief in the potential for sharing and scaling the application of health knowledge for the benefit of lives everywhere."

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.